Ausgabe 5/2012
Inhalt (14 Artikel)
Acute Myeloid Leukemia with Normal Cytogenetics
Raya Mawad, Elihu H. Estey
Diagnosis of Acute Leukemia in Cerebrospinal Fluid (CSF-Acute Leukemia)
Erick Crespo-Solis, Xavier López-Karpovitch, Jesús Higuera, Beatriz Vega-Ramos
Chronic Myeloid Leukemia: State of the Art in 2012
Carmen Fava, Giovanna Rege-Cambrin, Giuseppe Saglio
Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
Theresa Liu-Dumlao, Hagop Kantarjian, Deborah A. Thomas, Susan O’Brien, Farhad Ravandi
NK/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm
Ritsuro Suzuki
PET/CT Adapted Therapy in Hodgkin Disease: Current State of the Art and Future Directions
Eldad J. Dann
B-Cell Receptor Pathobiology and Targeting in NHL
Ines M. Macias-Perez, Ian W. Flinn
Transformation in Follicular Lymphoma: Biology, Prognosis, and Therapeutic Options
Eric Wong, Michael Dickinson
Active Immunotherapy: Current State of the Art in Vaccine Approaches for NHL
M. Lia Palomba
Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management
Michael A. Postow, Omid Hamid, Richard D. Carvajal
Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies
Janice M. Mehnert, Harriet M. Kluger
Screening and Prevention Measures for Melanoma: Is There a Survival Advantage?
Clara Curiel-Lewandrowski, Suephy C. Chen, Susan M. Swetter
Tumor-Infiltrating Lymphocytes in Melanoma
Sylvia Lee, Kim Margolin